Categories: Drug Research

Gelusil liquid antacid now available in a handy ready-to-consume sachet

 

Delhi, March 04, 2016: Pfizer’s GEP (Global Established Products) division in India announced the launch of its largest selling antacid Gelusil liquid in a ready-to-drink, on-the-go sachet format. The sachet aims to reach out to consumers who are constantly on the go and have to rely on multiple elements of cure to settle the acidity attacks. Being rolled out in metros, smaller towns and rural areas simultaneously, the Gelusil sachet is available across pharmacy stores and is priced at INR 8/- per sachet.

Commenting on this launch, Mr. Partha Ghosh, Senior Director (Global Established Products) said, “Acidity can be a recurring condition which can strike anyone, anytime, anywhere. It can cause heartburn and serious discomfort which can impact normal work. Research reveals that many who suffer from acidity do not take it seriously and either ignore it or resort to traditional methods to deal with acidity attacks. While traditional methods may provide symptomatic relief, it does not address the real issue. Gelusil’s balanced formula not only provides instant relief by neutralising the acid secreted but also provides long lasting relief by protecting the stomach lining from damage due to excessive acid”.

This newly launched easy-to-carry sachet has a unique proposition of a ready-to-consume solution for acidity that does not require water or a glass. It’s tamperproof packaging makes it convenient to carry and consume it just anytime / anywhere.

“We noticed that today’s on-the-go generation needs something that is easily accessible and portable. As a leading brand in the category it is important that we continuously look for newer and better ways of meeting the ever changing needs of the consumer. That’s how the idea of a sachet was born” added Mr Ghosh. Hurry, worry or curry can lead to acidity attacks. If you cannot avoid them, make Gelusil sachet your ally and be ready for the next party.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Kaivalyadhama to Host 11th International Conference on Yoga in Cancer Care, Uniting Global Experts to Explore Yoga’s Role in Holistic Cancer Support

Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…

6 hours ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

7 hours ago

From Pain to Relief: How endoscopic spine surgery enhances patient outcomes

By DR UMESH SRIKANTHA, Senior Consultant - Neurosurgery, Head of Spine Services, Aster RV Hospital …

1 day ago

Henkel India Unveils Dedicated Researchers’ World Lab in India

Pune, November 11, 2024: Henkel Adhesives Technologies India Private Limited (Henkel India) announces the opening…

1 day ago

Esaote Group Expands Production in India

Noida, November 08, 2024: Esaote Group, a leading Italian innovator in medical imaging - ultrasound,…

4 days ago

In Q2 FY25, AGI Greenpac Limited posts EBITDA of ₹166 crore up by 20% Y-o-Y and PAT of Rs ₹72 crore up by 28%

Gurugram, November 08, 2024: AGI Greenpac Limited, a focused Packaging Products company, today announced its financial…

4 days ago